52
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes

, &
Pages 893-899 | Published online: 28 Oct 2009

References

  • CreagerMALuscherTFCosentinoFDiabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part ICirculation20031081527153214504252
  • LuscherTFCreagerMABeckmanJADiabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part IICirculation20031081655166114517152
  • KalaniMThe importance of endothelin-1 for microvascular dysfunction in diabetesVasc Health Risk Manag200841061106819183753
  • KyriakidesZSKremastinosDTBofilisEEndogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriographyHeart20008417618210908255
  • HalcoxJPNourKRZalosGCoronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockadeCirc Res20018996997611717152
  • TakahashiKGhateiMALamHCElevated plasma endothelin in patients with diabetes mellitusDiabetologia1990333063102198188
  • MatherKJMirzamohammadiBLteifAEndothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetesDiabetes2002513517352312453909
  • SettergrenMPernowJBrismarKEndothelin-A receptor blockade improves nutritive skin capillary circulation in patients with type 2 diabetes and albuminuriaJ Vasc Res20084529530218212505
  • PiratBBozbasHSimsekVImpaired coronary flow reserve in patients with metabolic syndromeAtherosclerosis200820111211618374338
  • YonahaOMatsubaraTNaruseKEffects of reduced coronary flow reserve on left ventricular function in type 2 diabetesDiabetes Res Clin Pract2008829810318722029
  • InoueTSakaiYMorookaSExpression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplastyJ Am Coll Cardiol199628112711338890805
  • el-TamimiHDaviesGJCreaFResponse of human coronary arteries to acetylcholine after injury by coronary angioplastyJ Am Coll Cardiol199321115211578459070
  • CaramoriPRLimaVCSeidelinPHLong-term endothelial dysfunction after coronary artery stentingJ Am Coll Cardiol1999341675167910577555
  • KalaniMPernowJBragdJImproved peripheral perfusion during endothelin – a receptor blockade in patients with type 2 diabetes and critical limb ischemiaDiabetes Care200831e5618594055
  • BöhmFSettergrenMGononATThe endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humansClin Sci (Lond)200510835736315610070
  • De BruyneBPijlsNHSmithLCoronary thermodilution ta asssess flow reserve. Experimental validationCirculation20011042003200611673336
  • PijlsNHJDe BruyneBSmithLCoronary thermodilution to assess flow reserve: Validation in humansCirculation200210524802484
  • TookeJEPossible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetesJ Diabetes Complications20001419720011004428
  • KiniASKimMCMorenoPRComparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial)Am J Cardiol200810179680018328843
  • Rask-MadsenCKingGLMechanisms of disease: endothelial dysfunction in insulin resistance and diabetesNat Clin Pract Endocrinol Metab20073465617179929
  • ShoreACJaapAJTookeJECapillary pressure in patients with NIDDMDiabetes199443119812027926288
  • GallMARossingPSkottPPrevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patientsDiabetologia1991346556611955098
  • JaapAJHammersleyMSShoreACReduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitusDiabetologia1994372142168163058
  • VerhaarMCStrachanFENewbyDEEndothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockadeCirculation1998977527569498538
  • AhlborgGLindströmJInsulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humansJ Appl Physiol2002932112212112391119
  • DonatelliMCollettiIBucaloMLPlasma endothelin levels in NIDDM patients with macroangiopathyDiabetes Res1994251591647648786
  • AnfossiGRussoIDoronzoGRelevance of the vascular effects of insulin in the rationale of its therapeutical useCardiovasc Hematol Disord Drug Targets2007722824918220724
  • WedgwoodSMcMullanDMBekkerJMRole for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapyCirc Res2001178935736411509453
  • LiLFinkGDWattsSWEndothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertensionCirculation2003251071053105812600921
  • RomeroMJiménezRSánchezMQuercetin inhibits vascular superoxide production induced by endothelin-1: Role of NADPH oxidase, uncoupled eNOS and PKCAtherosclerosis2009202586718436224
  • MolenaarPO’ReillyGSharkeyACharacterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardiumCirc Res1993725265387679333
  • SakuraiTYanagisawaMMasakiTMolecular characterization of endothelin receptorsTrends Pharmacol Sci1992131031081315462
  • SeoBOemarBSSiebenmannRBoth ETA and ETB receptors mediate contraction to endothelin-1 in human blood vesselsCirculation199489120312088124808
  • IkenoFInagakiKRezaeeMImpaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damageCardiovasc Res20077369970917234167
  • MeimounPMalaquinDBenaliTNon-invasive coronary flow reserve after successful primary angioplasty for acute anterior myocardial infarction is an independent predictor of left ventricular recovery and in-hospital cardiac eventsJ Am Soc Echocardiogr2009221071107919647405
  • KitabataHImanishiTKuboTCoronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute myocardial infarctionJACC Cardiovasc Imaging2009226327219356570
  • AlbertalMVoskuilMPiekJJCoronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcomeCirculation20021051573157811927525
  • HerrmannJHaudeMLermanAAbnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevationCirculation20011032339234511352881
  • HalcoxJPNourKRZalosGQuyyumiAAEndogenous endothelin in human coronary vascular function: Differential contribution of endothelin receptor types A and BHypertension2007491134114117353514
  • GalderisiMde SimoneGD’ErricoAIndependent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertensionAm J Hypertens2008211040104618600214
  • GalderisiMCicalaSCasoPCoronary flow reserve and myocardial diastolic dysfunction in arterial hypertensionAm J Cardiol20029086086412372574
  • JarnertCLandstedt-HallinLMalmbergKA randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus And Diastolic Dysfunction) studyEur J Heart Fail200911394719147455